Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent Plasma for Severe and Critical COVID-19 Pneumonia
NCT04432103Phase 3Terminated
- Sponsor
- Centro Médico ABC
- Start
- Aug 2020
- Primary completion
- Jan 2021
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in COVID-19 pneumonia, sponsored by Centro Médico ABC. Started Aug 2020; status: terminated.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04432103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04432103.